A prospective, multicenter, open-label, randomized, comparative study to evaluate the efficacy, safety, and tolerability of ertapenem versus ceftriaxone/metronidazole in the treatment of intra-abdominal infections in adults

Trial Profile

A prospective, multicenter, open-label, randomized, comparative study to evaluate the efficacy, safety, and tolerability of ertapenem versus ceftriaxone/metronidazole in the treatment of intra-abdominal infections in adults

Completed
Phase of Trial: Phase III

Latest Information Update: 22 Feb 2017

At a glance

  • Drugs Ertapenem (Primary) ; Ceftriaxone; Metronidazole
  • Indications Bacterial infections; Intra-abdominal infections
  • Focus Therapeutic Use
  • Sponsors Merck & Co
  • Most Recent Events

    • 26 Jul 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top